Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

July 31, 2005

Conditions
Chronic Pain
Interventions
DRUG

Oxymorphone Extended Release

Trial Locations (33)

16602

Keystone Clinical Solutions, Altoona

19053

Feasterville Family Health Center, Feasterville

19426

Perkiomen Valley Family Practice, Collegeville

19522

Fleetwood Clinical Research, Fleetwood

19702

Glasgow Family Practice, Newark

27103

Piedmont Anesthesia, Winston-Salem

29576

Waccamaw Pain Management, Murrells Inlet

29651

Radiant Research, Greer

30338

Comprehensive Neurology Specialists, Atlanta

Comprehensive Neuroscience, Atlanta

32114

Radiant Research, Daytona Beach

32117

Century Clinical Research, Holly Hill

32720

University Clinical Research, DeLand

33024

University Clinical Research, Pembroke Pines

33324

Park Place Therapeutic Center, Plantation

33702

ICSL Clinical Studies, St. Petersburg

33781

Radiant Research, Pinellas Park

33907

LCFP Inc, Fort Myers

34474

Ocala Rheumatology Research Center, Ocala

34684

The Arthritis Center, Palm Harbor

35023

Southern Drug Research, Hueytown

60527

Pain Specialists of Greater Chicago, Burr Ridge

63141

Radiant Research, St Louis

64132

Research Medical Center, Kansas City

66211

Mid-America Physiatrists, Overland Park

75080

KRK Medical Research, Richardson

80909

Express Care Clinical Research, Colorado Springs

84102

Intermountain Clinical Research, Salt Lake City

84124

Jean Brown Research, Salt Lake City

85015

Phoenix Center for Clinical Research, Phoenix

06606

New England Research, Bridgeport

02920

New England Center for Clinical Research, Cranston

Paragon Clinical Research, Cranston

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY